Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,160 public trials 780 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Completed

Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma

NCT00504257

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Broward General Medical Center Cancer Center Fort Lauderdale, Florida, United States
  • Women's Cancer Associates St. Petersburg, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Duke Cancer Institute Durham, North Carolina, United States
View Trial Details
Completed

Study of Paclitaxel in Patients With Ovarian Cancer

NCT00989131

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Gomel Regional Clincial Oncology Center Homyel, Belarus
  • Minsk City Clinical Oncology Hospital Minsk, Belarus
  • Alexandrov National Cancer Center of Belarus Minsk, Belarus
  • Vitebsk Regional Clinical Oncology Center Vitebsk, Belarus
View all 84 locations
View Trial Details
Completed

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study

NCT01419249

Conditions
Bone Diseases, Bone Diseases, Developmental, Bone Diseases, Endocrine, +30 more
Locations
  • Hospital de Niños Ricardo Gutiérrez Buenos Aires, Argentina
  • Hospital de Pediatria Garrahan Buenos Aires, Argentina
  • Hospital de Niños de la Santisima Trinidad Córdoba, Argentina
  • University of Calgary - Alberta Children's Hospital Calgary, Canada
View all 31 locations
View Trial Details
Completed

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

NCT00667446

Conditions
Central Precocious Puberty (CPP), Depot Formulation, Endocrine System Diseases, +12 more
Locations
  • Site Reference ID/Investigator# 13521 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 14922 Long Beach, California, United States
  • Site Reference ID/Investigator# 26043 Los Angeles, California, United States
  • Site Reference ID/Investigator# 20802 San Diego, California, United States
View all 20 locations
View Trial Details

Related conditions